Countries China
Sino Biological Announces Services Partnership with Rapid Novor
This collaboration marks a significant stride in biotechnological services, covering major geographical regions including China, Singapore, Thailan...
March 22, 2024 | News
Antengene Advances ATG-022 in Phase II CLINCH Study for Solid Tumors in China and Australia,
Antengene Corporation Limited, a prominent global biopharmaceutical entity focused on the development and commercialization of pion...
March 21, 2024 | News
Chipscreen Biosciences Announces Successful Phase II Trial of Chiglitazar for NASH Treatment
The CGZ203 study, a randomized, double-blind, placebo-controlled trial conducted across 24 national clinical sites, aimed to assess the saf...
March 19, 2024 | News
KeChow Pharma's Tunlametinib Receives Historic Approval in China for Advanced Melanoma Treatment
KeChow Pharma, a commercial-stage pharmaceutical company focused on developing and commercializing differentiated small molecule therapeutics for cancer, t...
March 19, 2024 | News
CStone's Sugemalimab Granted Historic Approval in China for Gastric Cancer Treatment
CStone Pharmaceuticals has achieved a significant milestone with the approval of sugemalimab (Cejemly®) by the National Medical Products Administration...
March 18, 2024 | News
Sanyou Biopharmaceuticals Launches Groundbreaking Intelligent Innovative Biologics R&D Service Platform
Sanyou Biopharmaceutical Co., Ltd. is delighted to announce the official launch of the "Sanyou Intelligent Innovative Biologics R&D Service Platform," ...
March 13, 2024 | News
FDA Grants Nefecon® Orphan Drug Exclusivity for Seven Years
Everest Medicines licensing partner Calliditas Therapeutics AB announced that the U.S. FDA has granted an orphan drug exclusivity period of seven yea...
March 12, 2024 | News
TransThera Launches Global Phase 3 Trial for Cholangiocarcinoma in EU, Receives Orphan Drug Status for Tinengotinib from EMA
TransThera, a clinical-stage biopharmaceutical company dedicated to innovating differentiated drugs globally, today announced that the randomized, controll...
March 11, 2024 | News
Genesis MedTech and Silk Road Medical Partner to Treat Carotid Artery Disease in China
Since its establishment in 2019, Genesis MedTech Group has continuously strived to enhance its peripheral interventional portfolio, offering compre...
March 11, 2024 | News
Zylox-Tonbridge Forms Strategic Partnership with Avinger to Revolutionize Vascular Disease Treatment in Greater China
This partnership includes an exclusive right to Zylox-Tonbridge to localize, manufacture, and commercialize the entire product family developed by Avinger ...
March 08, 2024 | News
Innovent Biologics and AnHeart Therapeutics Secure Second NDA Acceptance for Groundbreaking Lung Cancer Treatment in China
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...
March 06, 2024 | News
WuXi Biologics attains leadership status in 2023 CDP Climate Change evaluation
CDP runs the global disclosure system for investors, companies, cities, states and regions to manage their environmental impact. In 2023, more than...
March 06, 2024 | News
YolTech's Gene Editing Therapy YOLT-201 Advances to Phase I Clinical Trials for Rare Genetic Disease
YolTech Therapeutics, a biotech company developing in vivo gene editing therapies to treat rare genetic diseases, announced the Center for Drug Evaluation ...
March 05, 2024 | News
Teva Partners with Jiangsu Nhwa to Enhance AUSTEDO® Access in China
“Nhwa has deep neuro-psychiatry expertise and capabilities, from research and development to commercialization,” commented Theodor Wee,...
February 28, 2024 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
- Eva van Pelt Joins Qiagen's Supervisory Board, Bringing a Wealth of Global Leadership Experience in Healthcare and Life Sciences
- Life Sciences Queensland Welcomes Dr. Kym Baker and Dr. Denise Hodge to Board Leadership
- Bayer appoints Nelson Ambrogio as new Head of Radiology Business at Pharmaceuticals Division
- Danaher Careers - Search Global Science and Technology Jobs
- Careers at MERCK Group
- Ajinomoto Bio-Pharma Services Announces Leadership Changes at US Facility
- Veranova Appoints Mike Riley as Chief Executive Officer
- Find your Job at Eppendorf
News
Editor Picks
